Search

Robert J Eom

Examiner (ID: 14076, Phone: (571)270-7075 , Office: P/1797 )

Most Active Art Unit
1797
Art Unit(s)
1797, 1772
Total Applications
735
Issued Applications
359
Pending Applications
80
Abandoned Applications
194

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18860390 [patent_doc_number] => 20230414824 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-28 [patent_title] => ANTIMICROBIAL OR WOUND CARE MATERIALS, DEVICES AND USES [patent_app_type] => utility [patent_app_number] => 18/215019 [patent_app_country] => US [patent_app_date] => 2023-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37952 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18215019 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/215019
ANTIMICROBIAL OR WOUND CARE MATERIALS, DEVICES AND USES Jun 26, 2023 Pending
Array ( [id] => 18707534 [patent_doc_number] => 20230330110 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-19 [patent_title] => HARD CAPSULE DOSAGE FORM AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/199117 [patent_app_country] => US [patent_app_date] => 2023-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25322 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18199117 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/199117
HARD CAPSULE DOSAGE FORM AND USES THEREOF May 17, 2023 Pending
Array ( [id] => 18672879 [patent_doc_number] => 20230310325 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-05 [patent_title] => High Surface-Area Lyophilized Compositions Comprising Arsenic For Oral Administration In Patients [patent_app_type] => utility [patent_app_number] => 18/160445 [patent_app_country] => US [patent_app_date] => 2023-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23662 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18160445 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/160445
High Surface-Area Lyophilized Compositions Comprising Arsenic For Oral Administration In Patients Jan 26, 2023 Pending
Array ( [id] => 18359304 [patent_doc_number] => 20230140895 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-11 [patent_title] => OPHTHALMIC SUSPENSION COMPOSITION [patent_app_type] => utility [patent_app_number] => 18/086286 [patent_app_country] => US [patent_app_date] => 2022-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10276 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18086286 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/086286
OPHTHALMIC SUSPENSION COMPOSITION Dec 20, 2022 Pending
Array ( [id] => 18281107 [patent_doc_number] => 20230096579 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-30 [patent_title] => ANTISEPTIC WOUND DRESSING [patent_app_type] => utility [patent_app_number] => 18/062678 [patent_app_country] => US [patent_app_date] => 2022-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3069 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 118 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18062678 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/062678
ANTISEPTIC WOUND DRESSING Dec 6, 2022 Pending
Array ( [id] => 18800107 [patent_doc_number] => 11833253 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2023-12-05 [patent_title] => Extended release pharmaceutical composition of Clozapine [patent_app_type] => utility [patent_app_number] => 17/967244 [patent_app_country] => US [patent_app_date] => 2022-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4840 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17967244 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/967244
Extended release pharmaceutical composition of Clozapine Oct 16, 2022 Issued
Array ( [id] => 18323185 [patent_doc_number] => 20230121313 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-20 [patent_title] => INTRANASAL ADMINISTRATION OF ESKETAMINE [patent_app_type] => utility [patent_app_number] => 17/890039 [patent_app_country] => US [patent_app_date] => 2022-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 128754 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 226 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17890039 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/890039
INTRANASAL ADMINISTRATION OF ESKETAMINE Aug 16, 2022 Pending
Array ( [id] => 18229114 [patent_doc_number] => 20230068108 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-02 [patent_title] => COMPOSITION AND METHOD HAVING ENHANCED LSESr TO MAINTAIN AND PROMOTE HAIR HEALTH AND GROWTH [patent_app_type] => utility [patent_app_number] => 17/818013 [patent_app_country] => US [patent_app_date] => 2022-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18885 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17818013 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/818013
COMPOSITION AND METHOD HAVING ENHANCED LSESr TO MAINTAIN AND PROMOTE HAIR HEALTH AND GROWTH Aug 7, 2022 Pending
Array ( [id] => 18043629 [patent_doc_number] => 11517562 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-12-06 [patent_title] => Pharmaceutical compositions [patent_app_type] => utility [patent_app_number] => 17/829736 [patent_app_country] => US [patent_app_date] => 2022-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 27 [patent_no_of_words] => 28105 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17829736 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/829736
Pharmaceutical compositions May 31, 2022 Issued
Array ( [id] => 18299166 [patent_doc_number] => 20230108852 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-06 [patent_title] => CONTROLLED RELEASE SYSTEM FOR PULMONARY DELIVERY OF SURFACTANT PROTEIN D [patent_app_type] => utility [patent_app_number] => 17/752418 [patent_app_country] => US [patent_app_date] => 2022-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5688 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17752418 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/752418
CONTROLLED RELEASE SYSTEM FOR PULMONARY DELIVERY OF SURFACTANT PROTEIN D May 23, 2022 Pending
Array ( [id] => 18784044 [patent_doc_number] => 20230371520 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-23 [patent_title] => Antimicrobial Polymer Composite [patent_app_type] => utility [patent_app_number] => 17/750760 [patent_app_country] => US [patent_app_date] => 2022-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3873 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17750760 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/750760
Antimicrobial Polymer Composite May 22, 2022 Pending
Array ( [id] => 17790317 [patent_doc_number] => 20220249408 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-11 [patent_title] => Articles with Active Agent Concentrated at the Substrate Contacting Surface and Related Methods [patent_app_type] => utility [patent_app_number] => 17/660515 [patent_app_country] => US [patent_app_date] => 2022-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13244 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17660515 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/660515
Articles with Active Agent Concentrated at the Substrate Contacting Surface and Related Methods Apr 24, 2022 Pending
Array ( [id] => 17958735 [patent_doc_number] => 20220339315 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-27 [patent_title] => ORGANOHYDROGEL FIBERS FOR SIMULTANEOUS RELEASE CONTROL OF HYDROPHILIC AND HYDROPHOBIC SUBSTANCES [patent_app_type] => utility [patent_app_number] => 17/724997 [patent_app_country] => US [patent_app_date] => 2022-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7871 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17724997 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/724997
ORGANOHYDROGEL FIBERS FOR SIMULTANEOUS RELEASE CONTROL OF HYDROPHILIC AND HYDROPHOBIC SUBSTANCES Apr 19, 2022 Pending
Array ( [id] => 17958606 [patent_doc_number] => 20220339186 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-27 [patent_title] => PROTON-BINDING POLYMERS FOR ORAL ADMINISTRATION [patent_app_type] => utility [patent_app_number] => 17/724105 [patent_app_country] => US [patent_app_date] => 2022-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 61888 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17724105 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/724105
Proton-binding polymers for oral administration Apr 18, 2022 Issued
Array ( [id] => 17748100 [patent_doc_number] => 20220226303 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-21 [patent_title] => MULTI-PHASE DELIVERY COMPOSITIONS AND PRODUCTS INCORPORATING SUCH COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 17/715274 [patent_app_country] => US [patent_app_date] => 2022-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13091 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17715274 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/715274
MULTI-PHASE DELIVERY COMPOSITIONS AND PRODUCTS INCORPORATING SUCH COMPOSITIONS Apr 6, 2022 Pending
Array ( [id] => 17748011 [patent_doc_number] => 20220226214 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-21 [patent_title] => METHOD FOR STABILIZING RETINOIC ACID PRECURSORS AND A SKIN BENEFIT COMPOSITION WITH STABILIZED RETINOIC ACID PRECURSORS [patent_app_type] => utility [patent_app_number] => 17/713573 [patent_app_country] => US [patent_app_date] => 2022-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4584 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17713573 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/713573
Method for stabilizing retinoic acid precursors and a skin benefit composition with stabilized retinoic acid precursors Apr 4, 2022 Issued
Array ( [id] => 17748224 [patent_doc_number] => 20220226427 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-21 [patent_title] => OPHTHALMIC COMPOSITION FOR TREATMENT OF DRY EYE DISEASE [patent_app_type] => utility [patent_app_number] => 17/711932 [patent_app_country] => US [patent_app_date] => 2022-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22279 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17711932 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/711932
OPHTHALMIC COMPOSITION FOR TREATMENT OF DRY EYE DISEASE Mar 31, 2022 Pending
Array ( [id] => 17702778 [patent_doc_number] => 20220202784 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-30 [patent_title] => METHODS AND COMPOSITIONS FOR INCREASING THE EFFECTIVENESS OF ANTIVIRAL AGENTS [patent_app_type] => utility [patent_app_number] => 17/697298 [patent_app_country] => US [patent_app_date] => 2022-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7972 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17697298 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/697298
METHODS AND COMPOSITIONS FOR INCREASING THE EFFECTIVENESS OF ANTIVIRAL AGENTS Mar 16, 2022 Abandoned
Array ( [id] => 17944294 [patent_doc_number] => 20220331311 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-20 [patent_title] => TABLET COMPRISING 7-[4-(4-BENZO[B]THIOPHEN-4-YL-PIPERAZIN-1-YL)BUTOXY]-1H-QUINOLIN-2-ONE OR A SALT THEREOF [patent_app_type] => utility [patent_app_number] => 17/653838 [patent_app_country] => US [patent_app_date] => 2022-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6615 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17653838 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/653838
TABLET COMPRISING 7-[4-(4-BENZO[B]THIOPHEN-4-YL-PIPERAZIN-1-YL)BUTOXY]-1H-QUINOLIN-2-ONE OR A SALT THEREOF Mar 6, 2022 Abandoned
Array ( [id] => 17805675 [patent_doc_number] => 20220257510 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-18 [patent_title] => Compositions for Nanoemulsion Delivery Systems [patent_app_type] => utility [patent_app_number] => 17/676573 [patent_app_country] => US [patent_app_date] => 2022-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7385 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17676573 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/676573
Compositions for Nanoemulsion Delivery Systems Feb 20, 2022 Pending
Menu